In the present paper, we verify the effectiveness of the two-relaxation-time (TRT) collision operator in reducing boundary slip computed by the immersed boundary-lattice Boltzmann method (IB-LBM). In the linear collision operator of the TRT, we decompose the distribution function into symmetric and antisymmetric components and define the relaxation parameters for each part. The Chapman-Enskog expansion indicates that one relaxation time for the symmetric component is related to the kinematic viscosity. Rigorous analysis of the symmetric shear flows reveals that the relaxation time for the antisymmetric part controls the velocity gradient, the boundary velocity, and the boundary slip velocity computed by the IB-LBM. Simulation of the symmetric shear flows, the symmetric Poiseuille flows, and the cylindrical Couette flows indicates that the profiles of the numerical velocity calculated by the TRT collision operator under the IB-LBM framework exactly agree with those of the multirelaxation time (MRT). The TRT is as effective in removing the boundary slip as the MRT. We demonstrate analytically and numerically that the error of the boundary velocity is caused by the smoothing technique using the δ function used in the interpolation method. In the simulation of the flow past a circular cylinder, the IB-LBM based on the implicit correction method with the TRT succeeds in preventing the flow penetration through the solid surface as well as unphysical velocity distortion. The drag coefficient, the wake length, and the separation points calculated by the present IB-LBM agree well with previous studies at Re = 10, 20, and 40.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.